Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission.
about
Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remissionInterleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remissionIndividual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia.Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemiaVaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeostatic peripheral expansion after BMT.Optimal therapy for adult patients with acute myeloid leukemia in first complete remission.Enhancement of specific cellular immune response induced by DNA vaccines encoding PML-RARalpha and hIL-2 genes.Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia.Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation.High-dose idarubicin and busulphan as conditioning to autologous stem cell transplantation in adult patients with acute myeloid leukaemia.
P2860
Q24187927-7409A194-E5E0-4240-AA12-DC3F10A330BBQ24202630-69F3B06D-918A-4C9A-B937-CCBF1F87F1E9Q33881750-390D87C9-F443-4B8F-A219-CF9237B8A974Q34056156-D03EFB7D-DCB5-46D4-AE97-9634C72BF99BQ35210494-2707A55C-1794-4A51-A31A-B3439BEC63BCQ35850723-27FA92E7-7AE8-4171-A36E-A856C094302CQ38208953-0F9D4017-C1EB-4C23-BF6C-5A7E658B4012Q39710209-8E4A0FEB-37EB-4AD0-B6AB-235F80973811Q44849776-A76FC168-7B61-48A5-9C0E-D7FBEA3C7FC2Q44982489-09175496-1DDB-4F27-A9B5-823B635CBF42Q45215896-E629EDB1-90C4-48D0-9F19-A1BDE37EA694
P2860
Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Interleukin-2 after autologous ...... a in first complete remission.
@ast
Interleukin-2 after autologous ...... a in first complete remission.
@en
type
label
Interleukin-2 after autologous ...... a in first complete remission.
@ast
Interleukin-2 after autologous ...... a in first complete remission.
@en
prefLabel
Interleukin-2 after autologous ...... a in first complete remission.
@ast
Interleukin-2 after autologous ...... a in first complete remission.
@en
P2093
P356
P1476
Interleukin-2 after autologous ...... a in first complete remission.
@en
P2093
Amrita Krishnan
Andrew Dagis
Anthony S Stein
Arturo Molina
Auayporn P Nademanee
Daniel A Arber
David S Snyder
George Somlo
Henry C Fung
Joyce C Niland
P304
P356
10.1200/JCO.2003.12.125
P407
P577
2003-02-01T00:00:00Z